Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the use of high-sensitivity C-reactive protein as a biomarker in clinical decision making, and the role of perivascular adipose tissue in the pathogenesis of atherosclerosis from the virtual ESC Congress 2021.
Questions
- What is the rationale for the use of high-sensitivity C-reactive protein (hsCRP) as a biomarker in clinical decision making and what are its limitations? (0.15)
- What have we learned about the role of perivascular adipose tissue in the pathogenesis of atherosclerosis? (1.08)
Speaker disclosures: Prof. Charalambos Antoniades is founder, shareholder and director of Caristo Diagtnostics.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Prof. Charalambos Antoniades as a highlight of ESC 2021, August 2021.
